Reducción de las ganancias de las Farmacéuticas: Top 25 pharma companies by global sale

The rankings of the top 25 pharmaceutical companies have been compiled from GlobalData's pharmaceutical revenue figures, which are based on sales of prescription medicines, including generics drugs. The rankings include figures for 2013, 2012 

#	Company	2013 ($m)	2012 ($m)	Growth ($m)	Growth (%)
1	Pfizer	47878	51214	-3336	-7
2	Novartis	47468	46732	736	2
3	Roche	39163	38006	1156	3
4	Merck & Co.	37437	40601	-3164	-8
5	Sanofi	37124	39511	-2387	-6
6	GlaxoSmithKline	33330	33335	-5	0
7	Johnson & Johnson	28125	25351	2774	10
8	AstraZeneca	25711	27925	-2214	-9
9	Lilly	20962	20567	395	2
10	AbbVie	18790	18380	410	2
11	Teva	18308	18535	-227	-1
12	Amgen	18192	16639	1553	9
13	Takeda	17408	17562	-154	-1
14	Bristol-Myers Squibb	16385	17621	-1236	-8
15	Boehringer Ingelheim	15789	14655	1134	7
16	Novo Nordisk	14877	13890	987	7
17	Bayer	14854	14343	511	3
18	Astellas	13131	12599	532	4
19	Daiichi Sankyo	12067	11912	155	1
20	Otsuka	11226	10661	565	5
21	Gilead Sciences	10804	9398	1405	13
22	Baxter	10461	9976	485	5
23	Merck KGaA	8399	8504	-106	-1
24	Eisai	6783	6923	-140	-2
25	Biogen Idec	6668	5304	1364	20

Note: The 2013 ranking uses 2013 exchange rates for both its 2013 and 2012 values, to remove the effect of currency fluctuations. The 2012 ranking similarly uses 2012 exchange rates. Baxter's pharma 2013 revenues take account of its restructured reporting style under newly-named business units.